Literature DB >> 2948067

Detection of fluid overload by plasma concentration of human atrial natriuretic peptide (h-ANP) in patients with renal failure.

T Eisenhauer, J Talartschik, F Scheler.   

Abstract

There are no reliable parameters for the detection of fluid overload in anuric patients. In 70 patients on regular haemodialysis (HD) or haemofiltration (HF) treatment, plasma ANP IR concentrations were determined by radioimmunoassay and compared to 43 controls with normal renal function. ANP IR levels were markedly elevated immediately before HD or HF (m 82 fmol/ml) compared to ANP IR plasma concentrations after HD or HF (m 42 fmol/ml) and to ANP IR levels of healthy controls (m 19 fmol/ml). ANP IR was detected in haemofiltrates and found to be eliminated by HF. During isovolemic HF, ANP IR levels remained constant suggesting that ANP synthesis is much higher than elimination by HF and that the decrease in circulating volume at the end of HF or HD is the main stimulus for a lower secretion rate of ANP. Elevated ANP IR levels at the end of HD/HF were found to be associated with fluid overload even without clinical or radiographic symptoms. Consistent weight reduction was followed by a decrease of ANP IR levels.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2948067

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  11 in total

1.  [Atrial natriuretic factor levels and pressure in the pulmonary circulation before and after coronary dilatation].

Authors:  K H Scholz; J Marten; C Herrmann; U Spaar; U Tebbe; K L Neuhaus; H Kreuzer
Journal:  Klin Wochenschr       Date:  1990-08-17

2.  Binding sites of atrial natriuretic peptide in human renal tissue-quantification by in vitro receptor autoradiography.

Authors:  A Brucksch; H J Gröne; J Talartschik; E Fuchs
Journal:  Klin Wochenschr       Date:  1988-04-01

3.  [Behavior of the renal functional reserve in type I diabetic patients: effect of ACE-inhibition].

Authors:  T Eisenhauer; E Jungmann; D Warneboldt; G Ansorge; J Scherberich; J Talartschik
Journal:  Klin Wochenschr       Date:  1990-08-02

4.  Atrial natriuretic peptide and sodium homeostasis in chronic renal failure.

Authors:  T Tulassay; W Rascher; K Schärer
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

5.  [Modification of atrial natriuretic peptide (ANP) and cyclic GMP by hemofiltration and hemodialysis].

Authors:  T Eisenhauer; J Talartschik; E Quentin; W Kreutzfeldt; F Scheler
Journal:  Klin Wochenschr       Date:  1988-09-15

6.  The use of a monoclonal antibody for the determination of atrial natriuretic peptides in human plasma.

Authors:  J P Stasch; D Neuser; A John; D Hein; K Heuck; F J Morich
Journal:  Klin Wochenschr       Date:  1987-07-15

7.  Atrial natriuretic peptide and cyclic 3'5'-guanosine monophosphate as indicators of fluid volume overload in children with chronic renal failure.

Authors:  B Lettgen; M Bald; H Valleé; K E Bonzel; W Rascher
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

8.  Changes of molecular forms of atrial natriuretic peptide after treatment for congestive heart failure.

Authors:  F Marumo; T Kurosawa; S Takeda; Y Katoh; N Hasegawa; K Ando
Journal:  Klin Wochenschr       Date:  1988-08-01

9.  The role of natriuretic peptides in volume assessment and mortality prediction in Haemodialysis patients.

Authors:  Murugan Sivalingam; Enric Vilar; Suresh Mathavakkannan; Ken Farrington
Journal:  BMC Nephrol       Date:  2015-12-29       Impact factor: 2.388

Review 10.  Natriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence.

Authors:  Abhilash Koratala; Amir Kazory
Journal:  Dis Markers       Date:  2017-06-18       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.